“A Japanese university is to retract a study that touted the effectiveness of a blood pressure drug made by Swiss pharmaceutical giant Novartis because it was based on fabricated data. The move was the latest chapter in a growing scandal over allegations that bogus data were used in a string of Japanese university studies for the drug Valsartan which exaggerated its effectiveness in preventing strokes and angina. On Wednesday, Tokyo’s Jikei University School of Medicine said it would retract research that appeared in respected medical journal The Lancet six years ago.”
http://www.thelocal.ch/20130731/japanese-university-to-retract-novartis-drug-study
Related posts:
New Corporate Tax Shelter: A Merger Abroad
Woman Handing Out Samples at Va. Costco Shot Dead by Police
How The Alternative Minimum Tax Could Slam You
Tax-Free-Salaried OECD Calls For 'Income Inequality' Tax Overhaul
Germany asks top US intelligence official to leave the country
Nick Clegg's wealth tax is latest plan to make rich pay more
Pakistani flagmakers may see boost in sales after Obama victory spurs more effigies
Why the housing sector won’t save the broader economy
Top general: U.S. still has key Iraq role even after troop exit
Clear Bitcoin Tax Rules Needed, Taxpayer Advocate Says
Huntington’s gene therapy breakthrough may stop disease
Goldman to Fidelity Call for Calm After Global Stock Wipeout
NSA posed as Facebook to infect computers with malware: report
British warships arrive in Gibraltar amid tension with Spain
Scotland's independence could see descendants worldwide eligible for passport